CLOSING AGREEMENTClosing Agreement • September 19th, 2023 • Bioxytran, Inc • Pharmaceutical preparations
This Closing Agreement (the “Agreement”), dated as of September 18, 2023 (the “Issue Date”), is entered into between Bioxytran, Inc. a Nevada corporation (the “Company”), and TRITON FUNDS LP, a Delaware limited partnership (the “Investor”).
DEBT MODIFICATION AGREEMENTDebt Modification Agreement • September 19th, 2023 • Bioxytran, Inc • Pharmaceutical preparations • New York
THIS DEBT MODIFICATION AGREEMENT (this “Agreement”) is entered into as of May 5, 2022, by and among, Bioxytran, Inc., a Nevada corporation (the “Company”) and Walleye Opportunities Master Fund Ltd (“Purchaser”), each a “Party” and collectively the “Parties”, upon the following premises:
